According to a team of researchers at the University of Pennsylvania, one specific contributor to colon cancer may be a protein called MSI2.Read More
Imagine finally getting a knee replacement after dealing with years of crippling pain, only to develop a staph, or MRSA, infection at the surgery site. Not only is the pain still present, perhaps even worse, but rest of the body’s health is now at risk as well.Read More
Bioresearchers at Thomas Jefferson University in Philadelphia recently uncovered 3,400 new locations in the human genome that also produce miRNA molecules, offering up more options for further research into the relationship between miRNA and disease.Read More
Over 31 million Americans currently suffering from back pain can rest easy knowing that Pitt researchers are shouldering a new effort to study the condition - thanks to grants from the Patient-Centered Outcomes Research Institute (PCORI).
According to a university press release, the University of Pittsburgh will lead a 5-year, $14 million clinical trial to study intervention and early treatment options for back pain.
Researchers from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research have discovered a potential new method for treating brain cancer using specially engineered immune cells.
According to a university press release, personalized immune cells were engineered by UPenn scientists in order to seek out and attack a type of deadly brain cancer, and were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells.Read More
Researchers at Thomas Jefferson University may have found the ticket to helping men fight prostate cancer more efficiently and over a longer period of time. While prostate cancer is usually treatable in its early stages, men affected with cancer that has metastasized into their bones have a greatly reduced chance of fighting the deadly disease.
Researchers at Penn Medicine have gone through some great pains to find the first potential new class of novel anesthetics since the 1970s. Starting with a pool of over 350,000 compounds, they have isolated two compounds with the potential to be developed into new, safer general anesthetics.Read More
Earlier this year, the Thomas Jefferson University Medical School received a remarkable donation of $110 million dollars. This donation, from the Sidney Kimmel Foundation, renamed the medical school to the Sidney Kimmel Medical College at Thomas Jefferson University and will help enrich the school's facilities, students, faculty, and research.Read More
Premature birth, babies born before 37 weeks, can cause serious health problems for the half a million babies born early every year in the U.S. Health risks for premature babies include cerebral palsy, learning disabilities, vision and breathing problems, and hearing impairment. There are many different factors that can lead to preterm birth, but most of these factors are poorly understood. Further research is clearly needed to help better understand the causes of premature birth to lead to preventative methods. The March of Dimes Foundation of Philadelphia recently announced that it will donate $10 million over five years to establish a new Prematurity Research Center at the University of Pennsylvania. (Picture on right courtesy of Jennifer of Biotechnology Calendar, Inc.)Read More
Research lab scientists at the University of Pittsburgh recently received $10 million in research funding from the National Institute of Mental Health (NIMH) for studies focused on schizophrenia. The five-year science research grant will be used to establish the Silvio O. Conte Center for Translational Mental Health Research within the University of Pittsburgh School of Medicine’s Department of Psychiatry.